Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06329843 · ClinicalTrials.gov registry record
Intermountain Inpatient Bilirubin Decision Accuracy Study Using Smartphone-based Measurements by Picterus Jaundice Pro
A clinical trial of Neonatal Jaundice, sponsored by Picterus AS.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT06329843 is a study of Neonatal Jaundice that is actively recruiting participants, run by Picterus AS. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06329843, a study of Neonatal Jaundice, is actively recruiting participants, sponsored by Picterus AS.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to evaluate the performance of Picterus Jaundice Pro in an American population, including preterm and term newborns and pre- and post- phototherapy.
Conditions Studied
Interventions
- DEVICE Picterus Jaundice Pro (JP)
Study Locations (1)
Utah
- Intermountain Health - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2024-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06329843
The ClinicalTrials.gov registry entry for NCT06329843 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Picterus AS, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neonatal Jaundice appearing as the primary indexed condition, and to 1 intervention - of which Picterus Jaundice Pro (JP) is the first listed.
NCT06329843 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT06329843 about?
NCT06329843 is a clinical study titled "Intermountain Inpatient Bilirubin Decision Accuracy Study Using Smartphone-based Measurements by Picterus Jaundice Pro". The goal of this project is to evaluate the performance of Picterus Jaundice Pro in an American population, including preterm and term newborns and pre- and post- phototherapy.
What is the current status of trial NCT06329843?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-02-12. Estimated completion is 2024-05.
What conditions does trial NCT06329843 study?
This clinical trial studies the following conditions: Neonatal Jaundice.
What interventions are being tested in trial NCT06329843?
The interventions under investigation include: Picterus Jaundice Pro (JP) (DEVICE).
Who is sponsoring clinical trial NCT06329843?
This trial is sponsored by Picterus AS, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06329843 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neonatal Jaundice
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.